Tuesday, November 29, 2022

Partner News

NICE recommends VAZKEPA® (icosapent ethyl) to reduce cardiovascular risk

NICE recommends VAZKEPA® (icosapent ethyl) to reduce cardiovascular risk

Icosapent ethyl has been recommended by NICE for use across the NHS in England and Wales to reduce cardiovascular (CV) risk in adult statin-treated...
cancer

Defence Therapeutics provides an update on its numerous anti-cancer projects

Biotechnology pioneers Defence Therapeutics outline its current research and development progress in a plethora of anti-cancer endeavours. In Q1 of 2022, Defence signed an agreement...
B Medical Systems receives WHO prequalification for their U201 ultra-low freezer

B Medical Systems receives WHO prequalification for their U201 Ultra-low freezer

B Medical Systems, a global leader in medical cold chain solutions, has announced that the company’s Ultra-Low Freezer U201 has received the world’s first...
AccuTOXTM

Defence Therapeutics move closer to AccuTOXTM Phase I clinical trial

Defence Therapeutics has established an agreement with CATO SMS, who will advise on submitting the company’s clinical application to Health Canada to initiate a...
HPV vaccine

Defence Therapeutics’ HPV vaccine achieves a higher humoral response than Gardasil-9

Canadian biotechnology company Defence Therapeutics has revealed that its novel HPV vaccine has demonstrated a higher humoral response than the Gardasil-9 vaccine. The company’s new...
B Medical Systems launches its manufacturing facility in Mundra, Gujarat

B Medical Systems launches its manufacturing facility in Mundra, Gujarat

B Medical Systems, a global leader in medical cold chain solutions, headquartered in Luxembourg, has inaugurated its new Indian manufacturing facility in Mundra, Gujarat...
Defence Therapeutics achieves major milestone with anti-cancer molecule 

Defence Therapeutics achieves major milestone with anti-cancer molecule 

Biotechnology company Defence Therapeutics has announced the start of its final step in GLP studies on its anti-cancer AccuTOXTM molecule at Eurofins Advinus Limited...

B Medical Systems announces Andrea Scammacca as Chief Operating Officer

B Medical Systems, a global leader in medical cold chain products, has announced the appointment of Andrea Scammacca as its new Chief Operating Officer....
CRISPR

AccumTM platform greatly enhances CRISPR gene-editing technology

Defence Therapeutics has announced that its AccumTM platform can potently enhance Cas9 delivery in target cells, significantly advancing CRISPR gene-editing technology. The CRISPR technology offers...

B Medical systems announce Marnick Dewilde as Chief Sales Officer

B Medical Systems, a global leader in medical cold chain products, has announced the appointment of Marnick Dewilde as the Chief Sales Officer for...
XPhyto Therapeutics: rapid PCR test for COVID-19 in development

XPhyto Therapeutics: rapid PCR test for COVID-19 in development

XPhyto Therapeutics Corp. is a German-Canadian biotech company focused on next-generation drug formulations, diagnostics and novel pharmaceutical agents. The company is currently developing its...
Defence Therapeutics: changing the face of vaccines using AccumTM technology

Defence Therapeutics: changing the face of vaccines using AccumTM technology

Biotechnology specialists Defence Therapeutics are changing the face of vaccines using its AccumTM technology to enable precise delivery of proteins of pharmacological interest to...
Defence Therapeutics

Defence Therapeutics announces exciting addition to its board of directors

Biotechnology specialists Defence Therapeutics has revealed today that Dr Riam Shammaa has been appointed to its board of directors. Dr Riam Shammaa, MD, is a...
new COVID vaccine

Defence Therapeutics successfully test new COVID vaccine

Defence Therapeutics has sensationally revealed that they have successfully completed studies of their new COVID vaccine in a non-rodent rabbit model. The innovative new COVID...
healthy lifestyle

Maintaining an active and healthy lifestyle as we age in a digital world

Maintaining optimal physical condition becomes increasingly paramount as we age; to better understand how to achieve an active and healthy lifestyle, Aquarate discusses with...
breast cancer

AccumTM variants successfully increase breast cancer treatment potency

Biotechnology experts Defence Therapeutics have revealed strong in vitro results of its AccumTM variants on the ADC breast cancer treatment called Enhertu® (fam-trastuzumab-deruxtecan-nxki), which...
cancer vaccine

Defence Therapeutics prepares to test its DC cancer vaccine against melanoma

Defence Therapeutics is finalising all required steps in preparation for a pre-IND meeting to initiate a phase I trial against melanoma using its DC cancer...
cold chain

Vaccine cold chain pioneers inaugurate new factory extension

Luxemburg-based vaccine cold chain specialists B Medical Systems have conducted the opening ceremony of their cutting-edge factory extension at its corporate headquarters. The factory extension...
breast cancer treatment

Defence Therapeutics embark on next stage of breast cancer treatment development

In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
new COVID vaccine

Defence Therapeutics’ new COVID vaccine achieves successful testing

Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model. The new COVID vaccine – called...

Latest Health Partners

Latest Health eBooks

Pin It on Pinterest